Search clinical trials for: Docetaxel (D)

Total 6573 results

National Cancer Institute (NCI)

Completed

Docetaxel in Treating Children With Recurrent Solid Tumors

Sarcoma | Brain and Central Nervous System Tumors | Neuroblastoma

United States, Australia, Canada
Hanjong Ahn

Unknown

Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer

Prostate Cancer

Korea, Republic of
Pfizer

Terminated

Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects

Elderly, Frail

United States
Laval University

Active, not recruiting

Salmon Peptide Fraction: Safety and Cardiometabolic Health (SPF1)

Metabolic Syndrome

Canada
University of Bern
Swiss National Science Foundation

Completed

Evaluation of the Efficacy of Two Internet-based Self-help Interventions for Loneliness. (SOLUS-D)

Loneliness

Switzerland
Calhoun Vision, Inc.

Completed

Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)

Cataracts

United States, Mexico
University of Michigan Rogel Cancer Center
Sanofi

Terminated

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Prostate Cancer

United States
Samyang Biopharmaceuticals Corporation

Completed

A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

Korea, Republic of
National Guard Health Affairs

Suspended

Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer (TAXIS01)

Non-small Cell Lung Cancer Metastatic

Saudi Arabia
Samsung Medical Center

Unknown

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Nasopharyngeal Cancer

Korea, Republic of
Uppsala University
Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaborators

Not yet recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer (Lead4Care)

Prostate Cancer

Sweden
Sun Yat-sen University
Hunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Rhone-Poulenc Rorer

Completed

Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Roswell Park Cancer Institute

Terminated

Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Gastric Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Sanofi

Completed

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

Head and Neck Neoplasms

Tunisia, Morocco, Algeria
Spanish Lung Cancer Group

Terminated

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma (BREC)

Non Small Cell Lung Cancer | BRCA1 Mutation

Spain
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Breast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer
NanOlogy, LLC
US Biotest, Inc.

Withdrawn

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma of Kidney | Adenocarcinoma, Renal
NSABP Foundation Inc
AstraZeneca

Completed

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

Breast Neoplasms

United States
University of California, San Diego
Biotronik, Inc.

Completed

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds (CLASS)

Heart Failure | ICD | Chronotropic Incompetence

United States
Korean Society for Sexual Medicine and Andrology

Completed

Efficacy and Safety of DA-9401 on Improvement of Sperm Motility

Spermatocele

Korea, Republic of
University of Florida

Completed

Effect of D-allulose in Addition to Oral Sucrose Load

Blood Glucose

United States
Assistance Publique - Hôpitaux de Paris

Completed

Phenylbutyrate in Proteinuric Nephropathies (PIRATE)

Proteinuric Diseases

France
University of Manitoba
Canola Council of Canada; Alberta Innovates Bio Solutions; Alberta Canola Producers...

Completed

Effects of Canola Oil on Vascular and Metabolic Parameters in Individuals With Metabolic Syndrome (METCO-2013)

Metabolic Syndrome

Canada
Samsung Medical Center

Completed

Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

Advanced Gastric Adenocarcinoma

Korea, Republic of
First Affiliated Hospital of Guangxi Medical University

Unknown

Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC

Non-small Cell Lung Cancer
Incyte Corporation

Terminated

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Carcinoma)

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Aichi Cancer Center

Completed

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Japan
National Taiwan University Hospital

Completed

Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

NSCLC

Taiwan
Seagen Inc.

Completed

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

Non-Small Cell Lung Carcinoma

United States
Sanofi

Completed

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer (Tax-Over)

Ovarian Neoplasms

Turkey
Sanofi

Completed

Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

Cancer

United States, France, Canada, Russian Federation, Portugal, Argentina
GlaxoSmithKline

Completed

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Solid Tumor Cancer

United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Prostate Cancer

France
KU Leuven
Odisee University college for applied sciences

Not yet recruiting

Anxiety, Stress and Sleep Problems in People With Early Onset Dementia (Young-D)

Stress | Insomnia | Sleep | Anxiety | Distress, Emotional | Sleep Problem | Early Onset Dementia | Young Onset Dementia

Belgium
Ataturk University

Completed

Medium-Term Follow-Up of Alpha-D Cervical Disk Prosthesis

Cervical Disc Disease

Turkey
University of Oslo

Active, not recruiting

Cognitive Behavioural Therapy and Dental Fear

Dental Fear

Norway
Biotronik SE & Co. KG

Terminated

Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE)

Heart Failure

Germany, Czechia, Netherlands
Azienda Ospedaliero Universitaria Maggiore della...

Completed

Diaphragmatic Ultrasound in Acute Hypoxic - Hypercapnic Respiratory Failure (ARF) (DiaDea)

Acute Hypoxic - Hypercapnic Respiratory Failure (ARF)

Italy
Daphne Friedman
Keryx Biopharmaceuticals; Keryx / AOI Pharmaceuticals, Inc.

Completed

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
University of Miami

Completed

Biobehavioral Bases & Management of Type 2 Diabetes (CALM-D)

Type 2 Diabetes and Depression
Bioenergy Life Science, Inc.

Completed

The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind Study

Fatigue

United States
InventisBio Co., Ltd

Recruiting

Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

China
InventisBio Co., Ltd

Recruiting

A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer

NSCLC

China
InventisBio Co., Ltd

Completed

Study in Healthy Adult Female Subjects

Mass Balance Recovery

United States
Stanford University
National Heart, Lung, and Blood Institute (NHLBI); Medtronic Endovascular

Enrolling by invitation

The Use of FlowMet-R Technology to Predict Wound Healing in CLI Patients in a Wound Care Center Setting

Critical Limb Ischemia

United States
King's College London
University College, London

Completed

Healthy Eating & Active Lifestyles for Diabetes: Feasibility Trial (HEAL-D)

Type2 Diabetes

United Kingdom

Search clinical trials for: Docetaxel (D)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations